Pfizer's COVID-19 vaccine is 100% effective in 12 to 15 year olds, paving the way for approval for kids in the US and Europe

Pfizer BioNTech COVID-19 vaccine
Pfizer BioNTech COVID-19 vaccine

Pfizer-BioNTech's COVID-19 vaccine was 100% effective at preventing COVID-19 infection in kids aged 12 to 15 in late-stage trial of more than 2000 participants, the company announced Wednesday.

"In participants aged 12-15 years old, [Pfizer's COVID-19 vaccine] demonstrated 100% efficacy and robust antibody responses, exceeding those reported in trial of vaccinated 16-25 year old participants in an earlier analysis and it was well tolerated," Pfizer said in a press release.

Pfizer said its vaccine's side effects for 12 to 15 year olds as 16 to 25 year olds, but did not detail what they were.

As it stands, Pfizer's two-dose vaccine is authorized in 66 countries worldwide for those over 16 years old, including the US.

So far, more than 26.7 million adult Americans have been fully immunized with two doses of Pfizer's vaccine, according to the Centers for Disease Control and Prevention.

Pfizer plans to submit the data to the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) in order to request for emergency authorization of the vaccine.

Albert Bourla, Pfizer's chief executive officer, said: "We plan to submit these data to FDA as a proposed amendment to our Emergency Use Authorization in the coming weeks and to other regulators around the world, with the hope of starting to vaccinate this age group before the start of the next school year."

Pfizer started trials in 5 to 12 year olds on March 28. The company said Wednesday that it plans to initiate trials in 2-5 year old next week.

The story is developing. Check back for details.

Read the original article on Business Insider


from Business Insider https://ift.tt/3drMjWy

No comments

Powered by Blogger.